Gulf War Illness
37
9
9
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
5.4%
2 terminated out of 37 trials
90.5%
+3.9% vs benchmark
5%
2 trials in Phase 3/4
42%
8 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (37)
Collaborative Specialty Care for Gulf War Illness
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI
TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset
Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness
Resistant Potato Starch to Alleviate GWI
Machine Learning in Guiding rTMS Treatment for GWI-Related Headaches and Body Pain
rTMS in Alleviating Pain and Co-Morbid Symptoms in Gulf War Veterans Illness (GWVI)
Mechanisms of Gulf War Illness
Ca-Mg Butyrate in GWI
OEA for Targeting Lipid Metabolism in GWI
Nicotinamide Riboside Clinical Trial for GWI
Validating Gulf War Illness Blood Biomarkers
Study of Bacopa in Gulf War Illness Patients
Identification of Gulf War Illness (GWI) Biomarkers
Effects of Botanical Microglia Modulators in Gulf War Illness
Confirmation of Diet as a Treatment for Gulf War Illness
Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms
Coenzyme Q10 Phase III Trial in Gulf War Illness
Research Examining Gulf War Illness in Our Nations Service Members